Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for ZNTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 215.33M
March 31, 2026 253.07M
December 31, 2025 288.97M
September 30, 2025 327.25M
June 30, 2025 351.71M
March 31, 2025 384.02M
December 31, 2024 430.34M
September 30, 2024 450.66M
June 30, 2024 491.68M
March 31, 2024 557.48M
December 31, 2023 562.03M
September 30, 2023 585.72M
June 30, 2023 621.44M
March 31, 2023 489.34M
Date Value
December 31, 2022 553.46M
September 30, 2022 529.19M
June 30, 2022 567.86M
March 31, 2022 405.68M
December 31, 2021 472.02M
September 30, 2021 435.08M
June 30, 2021 283.96M
March 31, 2021 328.35M
December 31, 2020 366.19M
September 30, 2020 393.23M
June 30, 2020 257.22M
March 31, 2020 87.63M
December 31, 2019 88.23M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. 249.50M
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M

Total Assets (Quarterly) Related Metrics